Tacrine Alzheimer's drug molecule

Tacrine Alzheimer's drug molecule

A624/0546 Rights Managed

Request low-res file

530 pixels on longest edge, unwatermarked

Request/Download high-res file

Uncompressed file size: 80.0MB

Downloadable file size: 920.1KB

Price image Pricing

Please login to use the price calculator


Caption: Tacrine. Molecular model of the Alzheimer's drug tacrine, marketed under the name Cognex. Atoms are represented as spheres and are colour-coded: carbon (blue), hydrogen (yellow) and nitrogen (dark blue). Tacrine belongs to a class of drugs known as acetylcholinesterase inhibitors. It inhibits the enzyme acetylcholinesterase, which destroys the neurotransmitter acetylcholine. Lack of neurotransmitters is thought to play a role in Alzheimer's disease, a common cause of dementia in the elderly. Tacrine does not cure the disease, or slow its progression, but it can improve cognitive function.

Release details: Model release not required. Property release not required.

Keywords: 1, acetylcholine, acetylcholinesterase, alzheimer's disease, biochemical, biochemistry, biological, biology, chemical, chemistry, cholinesterase inhibitor, cognex, compound, compounds, cut out, cut-out, cutout, drug, illustration, inhibition, medical, medicine, molecular, molecular model, molecule, molecules, neurodegenerative, one, pharmaceutical, pharmaceutics, pharmacological, pharmacology, single, space fill, space-fill, spacefill, structure, tacrine, therapy, treatment

Licence fees: A licence fee will be charged for any media (low or high resolution) used in your project.